Department of Surgery, Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Surgery, ZGT Hospital Group Twente, Almelo, The Netherlands.
Dis Esophagus. 2022 Dec 14;35(12). doi: 10.1093/dote/doac020.
Anastomotic leak (AL) is a severe complication after esophagectomy. Clinical presentation of AL is diverse and there is large practice variation regarding treatment of AL. This study aimed to explore different AL treatment strategies and their underlying rationale. This mixed-methods study consisted of an international survey among upper gastro-intestinal (GI) surgeons and focus groups with expert upper GI surgeons. The survey included 10 case vignettes and data sources were integrated after separate analysis. The survey was completed by 188 respondents (completion rate 69%) and 6 focus groups were conducted with 20 international experts. Prevention of mortality was the most important goal of primary treatment. Goals of secondary treatment were to promote tissue healing, return to oral feeding and safe hospital discharge. There was substantial variation in the preferred treatment principles (e.g. drainage or defect closure) and modalities (e.g. stent or endoVAC) within different presentations of AL. Patients with local symptoms were treated by supportive means only or by non-surgical drainage and/or defect closure. Drainage was routinely performed in patients with intrathoracic collections and often combined with defect closure. Patients with conduit necrosis were predominantly treated by resection and reconstruction of the anastomosis or by esophageal diversion. This mixed-methods study shows that overall treatment strategies for AL are determined by vitality of the conduit and presence of intrathoracic collections. There is large variation in preferred treatment principles and modalities. Future research may investigate optimal treatment for specific AL presentations and aim to develop consensus-based treatment guidelines for AL after esophagectomy.
吻合口漏(AL)是食管切除术后的一种严重并发症。AL 的临床表现多种多样,其治疗方法也存在很大的差异。本研究旨在探讨不同的 AL 治疗策略及其潜在的原理。这项混合方法研究包括对上消化道(GI)外科医生进行国际调查和与上消化道外科专家进行焦点小组讨论。该调查包括 10 个病例描述,在单独分析后整合了数据来源。该调查由 188 名受访者(完成率为 69%)完成,并进行了 6 个焦点小组,共有 20 名国际专家参加。初级治疗的最重要目标是预防死亡率。二级治疗的目标是促进组织愈合、恢复口服喂养和安全出院。在不同的 AL 表现中,首选的治疗原则(例如引流或缺陷闭合)和方法(例如支架或内 VAC)存在很大差异。局部症状的患者仅接受支持性治疗或非手术引流和/或缺陷闭合。有胸腔内积液的患者常规进行引流,常与缺陷闭合相结合。管腔坏死的患者主要通过吻合口切除和重建或食管转流来治疗。这项混合方法研究表明,AL 的总体治疗策略取决于管腔的活力和胸腔内积液的存在。首选的治疗原则和方法存在很大差异。未来的研究可能会针对特定的 AL 表现探索最佳的治疗方法,并旨在为食管切除术后的 AL 制定基于共识的治疗指南。